CartilaGen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

CartilaGen General Information

Description

Developer of disease-modifying small-molecule drugs intended to prevent osteoarthritis after traumatic injury. The company's drugs offer joint lubrication that is nontoxic and inexpensive, enabling healthcare providers to treat their patients and improve their lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2501 Crosspark Road
  • Unit E156M
  • Coralville, IA 52241
  • United States
+1 (319)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2501 Crosspark Road
  • Unit E156M
  • Coralville, IA 52241
  • United States
+1 (319)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CartilaGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private Completed Generating Revenue
9. Grant 21-Nov-2022 Completed Generating Revenue
8. Grant 25-May-2021 Completed Generating Revenue
7. Grant 01-Oct-2020 Completed Generating Revenue
6. Accelerator/Incubator 06-Jun-2020 Completed Generating Revenue
5. Later Stage VC Completed Startup
4. Grant 16-Sep-2019 Completed Startup
3. Grant 02-May-2016 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view CartilaGen’s complete valuation and funding history, request access »

CartilaGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CartilaGen Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Iowa Economic Development Authority Government
Regnier Venture Creation Challenge Other
Wellmark (Medical) Corporation
UIVentures Accelerator/Incubator Minority
NIACC John Pappajohn Entrepreneurial Center Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

CartilaGen FAQs

  • When was CartilaGen founded?

    CartilaGen was founded in 2014.

  • Where is CartilaGen headquartered?

    CartilaGen is headquartered in Coralville, IA.

  • What is the size of CartilaGen?

    CartilaGen has 3 total employees.

  • What industry is CartilaGen in?

    CartilaGen’s primary industry is Drug Discovery.

  • Is CartilaGen a private or public company?

    CartilaGen is a Private company.

  • What is CartilaGen’s current revenue?

    The current revenue for CartilaGen is .

  • Who are CartilaGen’s investors?

    Iowa Economic Development Authority, Regnier Venture Creation Challenge, Wellmark (Medical), UIVentures, and NIACC John Pappajohn Entrepreneurial Center are 5 of 10 investors who have invested in CartilaGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process